Navigation Links
GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting
Date:6/23/2009

ATLANTA, June 23 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biopharmaceutical company developing human vaccines for diseases caused by the HIV-1 (Human Immunodeficiency Virus), and other infectious agents, today announced the results of its Annual Shareholders Meeting, held on June 18, 2009.

During the meeting, shareholders re-elected seven nominees for directors of the company to serve until the 2010 Annual Meeting of Shareholders and until their successors are duly elected or appointed and qualified. They are: Donald Hildebrand, Andrew Kandalepas, Dean Kollintzas, Robert McNally, Harriet Robinson, John Spencer and Peter Tsolinas. Additionally, stockholders ratified the appointment of Porter Keadle Moore LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2009.

Don Hildebrand, company co-founder and Chairman of the Board of Directors, provided opening remarks at the meeting, highlighting significant progress over the past year. A few of the key advances presented included: GeoVax as being the only company currently conducting Phase 2a clinical trials for an AIDS vaccine in the U.S., excellent safety and immune responses being reported in five completed human trials, the advancement of plans to begin human therapeutic [treatment] trials in the U.S., stable corporate financial condition, rising recent stock price, substantial increase in the number of new investors in GeoVax, substantial press coverage and investor interest at the World BIO Conference in Atlanta, invitations to present GeoVax at various investor conferences and several scientific presentations and publications by Dr. Robinson in the U.S. as well as in Europe.

In addition to the business of the annual meeting, Robert McNally, president and chief executive officer, provided an overview of the company's progress, highlighting GeoVax's
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
2. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
3. Excellent Results Received from GeoVaxs Full-Dose HIV/AIDS Vaccine Trial
4. GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update
5. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
6. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
7. Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
8. GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
9. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
10. GeoVax Secures $10 Million Financing Commitment
11. GeoVax Reports Progress on Its AIDS Vaccine Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... SAN DIEGO, July 31, 2014 Tandem Diabetes Care®, ... and manufacturer of the t:slim® Insulin Pump, today reported its ... In comparing the second quarter of 2014 to ... percent to $10.3 million from $5.5 million , t:slim ... pumps In comparing six months ended June 30, ...
(Date:7/31/2014)... , July 31, 2014  Alexza Pharmaceuticals, Inc. ... update on its pipeline and new product development ... to initiate a Phase 2a study of AZ-002 ... for the management of patients with acute repetitive ... Staccato -based product candidates for development - AZ-008 ...
(Date:7/31/2014)... July 31, 2014  Decision Resources Group is launching ... product Marketrack to now include ChinaTrack; the new capabilities ... in an interactive dashboard providing detailed brand-level share tracking ... a hospital level. Other key capabilities of ... feed: In addition to end-user surveys of healthcare facilities, ...
Breaking Medicine Technology:Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 3Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 4Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 5Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 6Alexza Provides Pipeline Update 2Alexza Provides Pipeline Update 3Alexza Provides Pipeline Update 4Alexza Provides Pipeline Update 5Alexza Provides Pipeline Update 6Decision Resources Group Announces First Medical Device Account Targeting Tool in China 2
(Date:7/31/2014)... July 31, 2014 Bedford Commons ... firm Innerspire: Brand ReEnergizers to do what ... how we connect with the community all while still ... area practice, which caters to women’s health needs for ... and total women focused care ( Gynecology ), worked ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Dr. Andrew ... American Board of Dermatology, fellowship trained Mohs surgeon that ... Top Docs. , After extensive dermatology research training at ... Health, Dr. Li completed his internship in internal medicine ... University of Pennsylvania in Philadelphia. Dr. Li pursued further ...
(Date:7/31/2014)... has been rising steadily in the U.S in recent ... and Health, the number of individuals reporting past year ... (669,000). Emerging evidence suggests the increase may be linked ... and/or intranasal PO use to heroin use, with POs ... heroin injection. This drug-use trajectory appears to have ...
(Date:7/31/2014)... 2014 Model moms are believers. PBS has ... positions in the field have grown exponentially in the last ... thriving industry, there are associated myths that need to be ... Frontier Nursing University . Celebrating 75 years in 2014, ... in the nation. “Frontier is changing the face of ...
(Date:7/31/2014)... Infection prevention and control is the ... products in the pharma, medical device, and food industries. ... products and equipment types; the two procedures prevent the ... products. , The world market for infection prevention ... a CAGR of about 7.5% through to 2018. The ...
Breaking Medicine News(10 mins):Health News:Doctor Videos & Women’s Stories Jumpstart Local OB-GYN Practice 2Health News:Doctor Videos & Women’s Stories Jumpstart Local OB-GYN Practice 3Health News:Doctor Videos & Women’s Stories Jumpstart Local OB-GYN Practice 4Health News:NJ Top Docs Proudly Presents Approved Provider, Dr. Andrew Li of Warren Skin Care Center 2Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 2Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 3Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 2Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 3Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 4Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 5Health News:Infection Prevention and Control Market to Post about 7.5% CAGR through 2018, States Infiniti Research in Its Study Published at MarketPublishers.com 2Health News:Infection Prevention and Control Market to Post about 7.5% CAGR through 2018, States Infiniti Research in Its Study Published at MarketPublishers.com 3
... from across Pennsylvania with substantial experience in ... Sept. 11 The Pennsylvania,Patient Safety Authority,s Board ... control experts to help implement Act 52 of ... Ed Rendell in July to help reduce and,eliminate ...
... Sally Watkins, PhD(c), MS, RN, has been named ... the Washington State Nurses,Association (WSNA), the State,s oldest ... are very fortunate to have in Sally Watkins ... and nurse advocate," said WSNA Executive,Director Judy Huntington, ...
... a mid-August edition of Circulation: Journal of the America Heart ... eating habits, it can strongly influence their heart disease risk ... Coronary Risk Factor Intervention Project have landmark implications on how ... a childs fat intake, primarily reduction in intake of saturated ...
... power industry is riding the green wave back into ... to our growing energy needs. But even as the ... play, it is bound by a global energy landscapefrom ... the marketplace. , Veteran New York Times energy ...
... shows no improvement with carvedilol , , TUESDAY, Sept. 11 (HealthDay News) ... that has been effective for adults with heart failure, did not ... rate of improvement -- and the lack of it -- was ... drug as it was for 54 youngsters who got a placebo. ...
... of prostate biopsies resulted in a cancer diagnosis among ... first biopsy did not find cancer often had multiple ... a cancer diagnosis. , While PSA (prostate-specific antigen) ... a biopsy is what actually determines the presence of ...
Cached Medicine News:Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 2Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 3Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 4Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 5Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 6Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 7Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 8Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 9Health News:New Director of Nursing Practice Named for Nurses Association 2Health News:Children who learn heart healthy eating habits lower heart disease risk 2Health News:Children who learn heart healthy eating habits lower heart disease risk 3Health News:Trade-offs reveal no clear favorites in alternative energy market 2Health News:Beta Blocker Doesn't Help Children With Heart Failure 2Health News:Other highlights in the September 11 JNCI 2Health News:Other highlights in the September 11 JNCI 3
HbA1c / HbCalibrator...
Control Plasma for Assays of Low MolecularWeight Heparins (LMWH) using Anti-Xa Method on STA© Analyzers....
... Abnormal Control Plasmas for ... D-dimer and Free Protein ... For use with STA© ... D-DI (#0515) andSTA© LIATEST© ...
CRP Full Range (0.1-160mg/l)...
Medicine Products: